Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
ID: PAS-22-197 • Type: Posted
Opportunity Assistant
Loading
Overview
Category of Funding
Health
Funding Instruments
Grant
Grant Program (CFDA)
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 6/21/22 the National Institutes of Health posted grant opportunity PAS-22-197 for Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional).
The grant will be issued under grant program 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders.
Timing
Posted Date
June 21, 2022, 12:00 a.m. EDT
Closing Date
Sept. 5, 2025, 12:00 a.m. EDT Past Due
Last Updated
June 21, 2022, 11:02 a.m. EDT
Version
1
Archive Date
Oct. 11, 2025
Eligibility
Eligible Applicants
Small businesses
Additional Info
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Award Sizing
Ceiling
$1,838,436
Floor
Not Listed
Estimated Program Funding
Not Provided
Estimated Number of Grants
Not Listed
Contacts
Contact
National Institutes of Health
Contact Email
Email Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Contact Phone
(301) 402-2541
Additional Information Site